Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 157 articles: HTML format

Single Articles

July 2025
1. IROWA O, Adeyeye OS, Ujah OI, Ogwuche PE, et al
   Assessment of barriers to cervical cancer screening at primary health care centers in Makurdi, North-Central Nigeria: a mixed-methods study.
   BMC Cancer. 2025;25:1099.
   PubMed     Abstract available
   
   
   
2. TONGHUI B, Wufen L, Lin Q
   Single-cell sequencing reveals the role of SALL4 in cervical cancer development.
   BMC Cancer. 2025;25:1086.
   PubMed     Abstract available
   
   
   
3. MANDIWA C, Sanna M, Gao W
   Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.
   BMC Cancer. 2025;25:1052.
   PubMed     Abstract available
   
   
   
4. SEIFU BL, Asnake AA, Belayneh T, Hailemariam T, et al
   Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022.
   BMC Cancer. 2025;25:1067.
   PubMed     Abstract available
   
   
   
5. SHARMA U, Yadav BK, Rai U, Pradhan A, et al
   Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study.
   BMC Cancer. 2025;25:1098.
   PubMed     Abstract available
   
   
   May 2025
6. YE Y, Chen Y, Pan J, Li P, et al
   Integrating SEResNet101 and SE-VGG19 for advanced cervical lesion detection: a step forward in precision oncology.
   BMC Cancer. 2025;25:963.
   PubMed     Abstract available
   
   
   
7. WANG Y, Lin AY, Wang DD, Lin PP, et al
   In situ phenotypic and karyotypic co-detection of aneuploid TCs and TECs in cytological specimens with abnormal cervical screening results.
   BMC Cancer. 2025;25:945.
   PubMed     Abstract available
   
   
   
8. LI K, Huang F, Zhang T, Yang F, et al
   HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study.
   BMC Cancer. 2025;25:885.
   PubMed     Abstract available
   
   
   
9. LI ZR, Wang YF, Zuo CR, Men JS, et al
   Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review.
   BMC Cancer. 2025;25:863.
   PubMed     Abstract available
   
   
   April 2025
10. YOON HY, Kim JM, Jeong YY, Lee YH, et al
    Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion.
    BMC Cancer. 2025;25:811.
    PubMed     Abstract available
    
    
    
11. KHIARI H, Abdelfatteh YB, Mahjoub N, Mekni K, et al
    Trends and projections in cervical cancer incidence in northern Tunisia (1994-2040).
    BMC Cancer. 2025;25:739.
    PubMed     Abstract available
    
    
    
12. ZHANG C, Chen L
    6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells.
    BMC Cancer. 2025;25:719.
    PubMed     Abstract available
    
    
    
13. XAVIER SP, Galvao ND, das Neves MAB, da Silva KM, et al
    Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil.
    BMC Cancer. 2025;25:684.
    PubMed     Abstract available
    
    
    
14. GE Y, Wu F, Zhang Y, Wang X, et al
    Prevalence of HPV infection and cervical lesions among women with pelvic organ prolapse and implications for preoperative evaluation.
    BMC Cancer. 2025;25:624.
    PubMed     Abstract available
    
    
    
15. TAGHADOS Z, Azimifar Z, Monsefi M, Jahromi MA, et al
    CausalCervixNet: convolutional neural networks with causal insight (CICNN) in cervical cancer cell classification-leveraging deep learning models for enhanced diagnostic accuracy.
    BMC Cancer. 2025;25:607.
    PubMed     Abstract available
    
    
    March 2025
16. WEN K, Wang L, Su H, Yu L, et al
    Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer.
    BMC Cancer. 2025;25:580.
    PubMed     Abstract available
    
    
    
17. ZHOU R, Xie Y, Wang Z, Liu Z, et al
    Single-cell transcriptomic analysis reveals CD8 + T cell heterogeneity and identifies a prognostic signature in cervical cancer.
    BMC Cancer. 2025;25:498.
    PubMed     Abstract available
    
    
    
18. ZENG S, Li X, Xiao S, Yang P, et al
    Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:502.
    PubMed     Abstract available
    
    
    
19. CAI G, Zhang S, Gao S, Deng T, et al
    What is the impact of perineural invasion on the prognosis of cervical cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:491.
    PubMed     Abstract available
    
    
    
20. LUO D, Yu Y, Wang Q, Peng T, et al
    The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis.
    BMC Cancer. 2025;25:450.
    PubMed     Abstract available
    
    
    February 2025
21. JIA SZ, Yang XJ, Yang D, Wang R, et al
    Low pretreatment prognostic nutritional index predicts unfavorable survival in stage III-IVA squamous cervical cancer undergoing chemoradiotherapy.
    BMC Cancer. 2025;25:377.
    PubMed     Abstract available
    
    
    
22. WU C, Lv X, Wang F, Xu Q, et al
    Predictors of distant metastasis or local recurrent after radiotherapy in patients with cervical cancer.
    BMC Cancer. 2025;25:364.
    PubMed     Abstract available
    
    
    
23. WU R, Wei Y, Wu A, Huang J, et al
    Performance of a six-methylation-marker assay in predicting LEEP specimen histology results of cervical HSIL patients: a retrospective study.
    BMC Cancer. 2025;25:340.
    PubMed     Abstract available
    
    
    
24. KUMAR S, Das B, Maurya G, Dey S, et al
    Limonoid-rich fraction from Azadirachta indica A. Juss. (neem) stem bark triggers ROS-independent ER stress and induces apoptosis in 2D cultured cervical cancer cells and 3D cervical tumor spheroids.
    BMC Cancer. 2025;25:334.
    PubMed     Abstract available
    
    
    
25. LI Y, Song W, Gao P, Guan X, et al
    Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021.
    BMC Cancer. 2025;25:330.
    PubMed     Abstract available
    
    
    
26. ZHOU K, Wang C, Zhao J, Chen J, et al
    Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer.
    BMC Cancer. 2025;25:324.
    PubMed     Abstract available
    
    
    
27. BA-ALAWI E, Azzani M, Alsaidi NA, Atroosh WM, et al
    Correction: Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
    BMC Cancer. 2025;25:320.
    PubMed    
    
    
    
28. OKYERE J
    Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey.
    BMC Cancer. 2025;25:259.
    PubMed     Abstract available
    
    
    
29. BEHERY MB, Bahbah AA, Mohamed Shawqi M, El-Said YM, et al
    Knowledge, attitude, and practice towards uterine cervical cancer screening in Egyptian females: a nationwide cross-sectional study.
    BMC Cancer. 2025;25:237.
    PubMed     Abstract available
    
    
    
30. WANG Y, Yu Y, Gu L, Sun Y, et al
    Radiomics feature is a risk factor for locally advanced cervical cancer treated using concurrent chemoradiotherapy based on magnetic resonance imaging: a retrospective study.
    BMC Cancer. 2025;25:230.
    PubMed     Abstract available
    
    
    
31. SWASE TD, Fasogbon IV, Eseoghene IJ, Etukudo EM, et al
    The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers.
    BMC Cancer. 2025;25:202.
    PubMed     Abstract available
    
    
    
32. ANANGWE N, Steimgrimson J, Cu-Uvin S
    Evaluation of pathology resources for cervical cancer detection between 2018 and 2022: a retrospective study at Moi Teaching and Referral Hospital, Western Kenya.
    BMC Cancer. 2025;25:203.
    PubMed     Abstract available
    
    
    
33. MA H, Ma L, Yang L, Cai M, et al
    Construction and evaluation of a prognostic model for cervical cancer based on dynamic hematological and clinical features.
    BMC Cancer. 2025;25:207.
    PubMed     Abstract available
    
    
    January 2025
34. PINTO-SANTINI D, Jalil EM, Fernandes GT, Hilaire G, et al
    ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIV.
    BMC Cancer. 2025;25:151.
    PubMed     Abstract available
    
    
    
35. WAGNER-LARSEN KS, Lura N, Gulati A, Ryste S, et al
    MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.
    BMC Cancer. 2025;25:122.
    PubMed     Abstract available
    
    
    
36. KHASAWNEH AI, Al Shboul S, Himsawi N, Al Rousan A, et al
    Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue.
    BMC Cancer. 2025;25:111.
    PubMed     Abstract available
    
    
    
37. BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al
    Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
    BMC Cancer. 2025;25:72.
    PubMed     Abstract available
    
    
    
38. GARG P, Krishnamoorthy Y, Halder P, Rajaa S, et al
    Urban-rural disparities in cervical cancer screening among Indian women between 30-49 years: a geospatial and decomposition analysis using a nationally representative survey.
    BMC Cancer. 2025;25:67.
    PubMed     Abstract available
    
    
    
39. SHEN T, Dong T, Wang H, Ding Y, et al
    Integrative machine learning frameworks to uncover specific protein signature in neuroendocrine cervical carcinoma.
    BMC Cancer. 2025;25:57.
    PubMed     Abstract available
    
    
    
40. BA-ALAWI E, Azzani M, Alsaidi NA, Atroosh WM, et al
    Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
    BMC Cancer. 2025;25:4.
    PubMed     Abstract available
    
    
    December 2024
41. ZHANG Z, Xie C, Zhao R, Wang S, et al
    Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions.
    BMC Cancer. 2024;24:1582.
    PubMed     Abstract available
    
    
    
42. SUN D, Shu C, Zeng F, Xu D, et al
    The performance of JAM3/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection.
    BMC Cancer. 2024;24:1514.
    PubMed     Abstract available
    
    
    
43. LIU Q, Zhu J, Abulizi G, Hasim A, et al
    Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma.
    BMC Cancer. 2024;24:1504.
    PubMed     Abstract available
    
    
    
44. XIA W, Dai X, Hu Y, Yang S, et al
    Value of intraoperative post-conisation human papillomavirus testing in predicting residual or recurrence after treatment with a loop electrosurgical excision procedure in women with HR-HPV positive and cervical high-grade squamous intraepithelial les
    BMC Cancer. 2024;24:1496.
    PubMed     Abstract available
    
    
    November 2024
45. AHMED HAA, Abbas MH, Hussein HA, Nasr RSF, et al
    Correction: Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.
    BMC Cancer. 2024;24:1478.
    PubMed    
    
    
    
46. CHEN C, Zhu B, Wang Y, Zhao Y, et al
    Incidence and risk factor of blood transfusion after abdominal radical hysterectomy for cervical cancer: a 10-year retrospective study of the US nationwide inpatient sample.
    BMC Cancer. 2024;24:1454.
    PubMed     Abstract available
    
    
    
47. AHMED HAA, Abbas MH, Hussein HA, Nasr RSF, et al
    Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.
    BMC Cancer. 2024;24:1438.
    PubMed     Abstract available
    
    
    
48. CHEN H, Ma Y, Wang D, Wu H, et al
    The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer.
    BMC Cancer. 2024;24:1405.
    PubMed     Abstract available
    
    
    
49. CHEN X, Jiang H, Xu H, Wang L, et al
    Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).
    BMC Cancer. 2024;24:1385.
    PubMed     Abstract available
    
    
    
50. EFFAH K, Tekpor E, Wormenor CM, Allotey J, et al
    Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana: a pilot study.
    BMC Cancer. 2024;24:1367.
    PubMed     Abstract available
    
    
    
51. ITO H, Yokoyama Y, Kyo S, Mandai M, et al
    Interim analysis of robot-assisted radical hysterectomy in Japan: a multicenter, prospective interventional single-arm clinical trial.
    BMC Cancer. 2024;24:1360.
    PubMed     Abstract available
    
    
    
52. DEDEY F, Nsaful J, Nartey E, Labi J, et al
    Assessing the impact of cervical cancer education in two high schools in Ghana.
    BMC Cancer. 2024;24:1359.
    PubMed     Abstract available
    
    
    
53. TAO H, Yu F, Yang L, Pei X, et al
    Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population.
    BMC Cancer. 2024;24:1352.
    PubMed     Abstract available
    
    
    October 2024
54. REMMEL ML, Suija K, Raudne R, Tisler A, et al
    Women's perspectives on the acceptability of risk-based cervical cancer screening.
    BMC Cancer. 2024;24:1314.
    PubMed     Abstract available
    
    
    
55. MEKONEN EG, Gebrehana DA, Tamir TT
    Determinants of cervical cancer screening among women of childbearing age in four sub-Saharan African countries: insights from large population surveys.
    BMC Cancer. 2024;24:1304.
    PubMed     Abstract available
    
    
    
56. YIRSAW AN, Tefera M, Bogale EK, Anagaw TF, et al
    Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1294.
    PubMed     Abstract available
    
    
    
57. TURNA M, Rzazade R, Kucukmorkoc E, Kucuk N, et al
    Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.
    BMC Cancer. 2024;24:1281.
    PubMed     Abstract available
    
    
    
58. FENG L, Shi Q, Wang S, Zhao Y, et al
    The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study.
    BMC Cancer. 2024;24:1267.
    PubMed     Abstract available
    
    
    
59. LI M, Xu T, Yang R, Wang X, et al
    Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.
    BMC Cancer. 2024;24:1258.
    PubMed     Abstract available
    
    
    
60. RASEKHI KAZERUNI A, Babaei N, Esmaeili Gouvarchin Ghaleh H, Doosti A, et al
    Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model.
    BMC Cancer. 2024;24:1253.
    PubMed     Abstract available
    
    
    September 2024
61. LUO H, Lian Y, Tao H, Zhao Y, et al
    Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.
    BMC Cancer. 2024;24:1171.
    PubMed     Abstract available
    
    
    
62. FANG C, Liu S, Xia J, Wu X, et al
    Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer.
    BMC Cancer. 2024;24:1170.
    PubMed     Abstract available
    
    
    
63. PENG L, Ai C, Dou Z, Li K, et al
    Altered microbial diversity and composition of multiple mucosal organs in cervical cancer patients.
    BMC Cancer. 2024;24:1154.
    PubMed     Abstract available
    
    
    
64. ZHAO YC, Li YF, Qiu L, Jin SZ, et al
    SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration.
    BMC Cancer. 2024;24:1133.
    PubMed     Abstract available
    
    
    
65. DABOUS E, Alalem M, Awad AM, Elawdan KA, et al
    Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells.
    BMC Cancer. 2024;24:1091.
    PubMed     Abstract available
    
    
    
66. FU J, Xu X, Tian M, Wang H, et al
    The controlling nutritional status score as a new prognostic predictor in patients with cervical cancer receiving radiotherapy: a propensity score matching analysis.
    BMC Cancer. 2024;24:1093.
    PubMed     Abstract available
    
    
    August 2024
67. TAO H, Chen Z, Yao B, Ren X, et al
    Galaxamide alleviates cisplatin-induced premature ovarian insufficiency via the PI3K signaling pathway in HeLa tumor-bearing mice.
    BMC Cancer. 2024;24:1060.
    PubMed     Abstract available
    
    
    
68. HAILEGEBIREAL AH, Bizuayehu HM, Tirore LL
    Far behind 90-70-90's screening target: the prevalence and determinants of cervical cancer screening among Sub-Saharan African women: evidence from Demographic and Health Survey.
    BMC Cancer. 2024;24:1050.
    PubMed     Abstract available
    
    
    
69. YE Y, Lian R, Li Z, Chen X, et al
    Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study.
    BMC Cancer. 2024;24:1005.
    PubMed     Abstract available
    
    
    
70. ARROSSI S, Straw C, Sanchez Antelo V, Paolino M, et al
    Implementation of WHO guidelines for cervical cancer screening, diagnosis and treatment: knowledge and perceptions of health providers from Argentina.
    BMC Cancer. 2024;24:996.
    PubMed     Abstract available
    
    
    
71. MON HM, Robb KA, Demou E
    Effectiveness of workplace cancer screening interventions: a systematic review.
    BMC Cancer. 2024;24:999.
    PubMed     Abstract available
    
    
    
72. LAKEW G, Yirsaw AN, Berhie AY, Belayneh AG, et al
    Cervical cancer screening practice and associated factors among female health care professionals in Ethiopia 2024: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:986.
    PubMed     Abstract available
    
    
    
73. BOUSKILL K, Wagner GJ, Gizaw M, Matovu JK, et al
    Understanding women's and men's perspectives on cervical cancer screening in Uganda: a qualitative study.
    BMC Cancer. 2024;24:933.
    PubMed     Abstract available
    
    
    July 2024
74. ANABA EA, Alor SK, Badzi CD, Mbuwir CB, et al
    Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.
    BMC Cancer. 2024;24:920.
    PubMed     Abstract available
    
    
    
75. HUANG M, Wang T, Li M, Qin M, et al
    Evaluating PAX1 methylation for cervical cancer screening triage in non-16/18 hrHPV-positive women.
    BMC Cancer. 2024;24:913.
    PubMed     Abstract available
    
    
    
76. YANG X, Zhou M, Luan Y, Li K, et al
    Identification of key genes associated with cervical cancer based on bioinformatics analysis.
    BMC Cancer. 2024;24:897.
    PubMed     Abstract available
    
    
    
77. CONG H, Yang X, Li Z, Li Z, et al
    Salvage radiotherapy for locally recurrent cervical and endometrial carcinoma: clinical outcomes and toxicities.
    BMC Cancer. 2024;24:871.
    PubMed     Abstract available
    
    
    
78. DE LA CRUZ-LOPEZ KG, Alvarado-Ortiz E, Valencia-Gonzalez HA, Beltran-Anaya FO, et al
    Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines.
    BMC Cancer. 2024;24:853.
    PubMed     Abstract available
    
    
    
79. YOU J, Yuan Y, Gu X, Wang W, et al
    Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.
    BMC Cancer. 2024;24:833.
    PubMed     Abstract available
    
    
    
80. SERMAN F, Lisembard G, Sahraoui M, Berkhout C, et al
    A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.
    BMC Cancer. 2024;24:807.
    PubMed     Abstract available
    
    
    June 2024
81. QIN L, Zhang L
    The predictive value of serum inflammatory markers for the severity of cervical lesions.
    BMC Cancer. 2024;24:780.
    PubMed     Abstract available
    
    
    
82. YANG W, Jin X, Huang L, Jiang S, et al
    Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population.
    BMC Cancer. 2024;24:776.
    PubMed     Abstract available
    
    
    
83. OKUNADE KS, Adejimi AA, Adekanye TV, Allsop MJ, et al
    Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial.
    BMC Cancer. 2024;24:751.
    PubMed     Abstract available
    
    
    
84. SIFER SD
    Survival status and predictors of mortality among cervical cancer patients at oncologic centers in Addis Ababa, Ethiopia: a follow up study.
    BMC Cancer. 2024;24:750.
    PubMed     Abstract available
    
    
    
85. HOSKIN P, Lee M, Dunkley D, Danh M, et al
    Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.
    BMC Cancer. 2024;24:702.
    PubMed     Abstract available
    
    
    
86. ALI B, Galbarczyk A, Jasienska G, Ba-Break M, et al
    Factors related to knowledge, attitudes, and behaviors regarding cervical cancer among Yemeni women.
    BMC Cancer. 2024;24:695.
    PubMed     Abstract available
    
    
    
87. FEREDE YA, Tassew WC, Zeleke AM
    Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
    BMC Cancer. 2024;24:678.
    PubMed     Abstract available
    
    
    May 2024
88. LI J, Yang Z, Wang T, Li M, et al
    Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.
    BMC Cancer. 2024;24:667.
    PubMed     Abstract available
    
    
    
89. AZIZ MA, Chowdhury S, Jafrin S, Barek MA, et al
    Genetic association of Interleukin-17A polymorphism in Bangladeshi patients with breast and cervical cancer: a case-control study with functional analysis.
    BMC Cancer. 2024;24:660.
    PubMed     Abstract available
    
    
    
90. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2024;24:655.
    PubMed     Abstract available
    
    
    
91. BUYUKBAYRAM ME, Hannarici Z, Turhan A, Caglar AA, et al
    A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
    BMC Cancer. 2024;24:626.
    PubMed     Abstract available
    
    
    
92. LYONNAIS E, Vigoureux S, Blondel B, Wylomanski S, et al
    Women's country of birth and failure to catch up an overdue cervical cancer cytological screening participation during pregnancy in France, an observational study based on survey sources.
    BMC Cancer. 2024;24:595.
    PubMed     Abstract available
    
    
    
93. WU Y, Jiang P, Chen Z, Li W, et al
    Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    BMC Cancer. 2024;24:589.
    PubMed     Abstract available
    
    
    
94. LEI L, Zhang L, Zheng Y, Ma W, et al
    Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    BMC Cancer. 2024;24:575.
    PubMed     Abstract available
    
    
    
95. ZHAO A, Pan Y, Gao Y, Zhi Z, et al
    MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
    BMC Cancer. 2024;24:559.
    PubMed     Abstract available
    
    
    April 2024
96. ZHOU Y, Wang W, Tang J, Hu K, et al
    Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    BMC Cancer. 2024;24:548.
    PubMed     Abstract available
    
    
    
97. ADAM JA, Poel E, van Eck Smit BLF, Mom CH, et al
    [(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
    BMC Cancer. 2024;24:513.
    PubMed     Abstract available
    
    
    
98. GU Z, Yang C, Zhang K, Wu H, et al
    Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
    BMC Cancer. 2024;24:492.
    PubMed     Abstract available
    
    
    
99. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
    Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
    BMC Cancer. 2024;24:450.
    PubMed     Abstract available
    
    
    
100. LI Z, Zhou G, Jiang L, Wang M, et al
     Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
     BMC Cancer. 2024;24:401.
     PubMed     Abstract available
     
     
     March 2024
101. LI X, Zhao Y, Xiang F, Zhang X, et al
     Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
     BMC Cancer. 2024;24:381.
     PubMed     Abstract available
     
     
     
102. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
     Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
     BMC Cancer. 2024;24:375.
     PubMed     Abstract available
     
     
     
103. CUI X, Wang H, Chen M, Seery S, et al
     Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
     BMC Cancer. 2024;24:349.
     PubMed     Abstract available
     
     
     
104. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
     Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
     BMC Cancer. 2024;24:351.
     PubMed     Abstract available
     
     
     
105. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
     Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
     BMC Cancer. 2024;24:308.
     PubMed     Abstract available
     
     
     
106. ZHANG Y, Liu S, Chen M, Ou Q, et al
     Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
     BMC Cancer. 2024;24:288.
     PubMed     Abstract available
     
     
     February 2024
107. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
     Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.
     BMC Cancer. 2024;24:259.
     PubMed     Abstract available
     
     
     
108. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
     Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
     BMC Cancer. 2024;24:243.
     PubMed     Abstract available
     
     
     
109. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
     Using administrative registries as a source for population-based cancer incidence and mortality.
     BMC Cancer. 2024;24:232.
     PubMed    
     
     
     
110. ZHONG ML, Liu YC, Yang JT, Wang YN, et al
     Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
     BMC Cancer. 2024;24:217.
     PubMed     Abstract available
     
     
     
111. XIAO L, Dong X, Sun J, Zhang X, et al
     Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
     BMC Cancer. 2024;24:169.
     PubMed     Abstract available
     
     
     
112. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
     Sociodemographic characteristics and their association with survival in women with cervical cancer.
     BMC Cancer. 2024;24:161.
     PubMed     Abstract available
     
     
     January 2024
113. LIU H, Cui Y, Chang C, Zhou Z, et al
     Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
     BMC Cancer. 2024;24:150.
     PubMed     Abstract available
     
     
     
114. PAN XB, Lu Y, Wei YS, Yao DS, et al
     Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
     BMC Cancer. 2024;24:106.
     PubMed     Abstract available
     
     
     
115. YU JH, Tong CJ, Huang QD, Ye YL, et al
     Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
     BMC Cancer. 2024;24:88.
     PubMed     Abstract available
     
     
     
116. KAIZILEGE GK, Ndaboine E, Chuma C, Mujuni F, et al
     Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
     BMC Cancer. 2024;24:66.
     PubMed     Abstract available
     
     
     
117. KUSSIA B, Shewangizaw M, Abebe S, Alemu H, et al
     Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
     BMC Cancer. 2024;24:38.
     PubMed     Abstract available
     
     
     December 2023
118. ZEWDIE A, Shitu S, Kebede N, Gashaw A, et al
     Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis.
     BMC Cancer. 2023;23:1228.
     PubMed     Abstract available
     
     
     
119. VIGNESHWARAN E, Goruntla N, Bommireddy BR, Mantargi MJS, et al
     Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
     BMC Cancer. 2023;23:1216.
     PubMed     Abstract available
     
     
     
120. KONG L, Xiao X, Xu T, Wan R, et al
     Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
     BMC Cancer. 2023;23:1211.
     PubMed     Abstract available
     
     
     November 2023
121. CHENG Z, Wang H, Yang Z, Li J, et al
     LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/beta-catenin signaling pathway and EMT in cervical cancer.
     BMC Cancer. 2023;23:1128.
     PubMed     Abstract available
     
     
     
122. ZHANG H, Yang Y, Xing W, Li Y, et al
     Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
     BMC Cancer. 2023;23:1124.
     PubMed     Abstract available
     
     
     
123. GLINSKA P, Komerska K, Janik B, Olkowicz J, et al
     HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
     BMC Cancer. 2023;23:1118.
     PubMed     Abstract available
     
     
     
124. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
     Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
     BMC Cancer. 2023;23:1104.
     PubMed     Abstract available
     
     
     
125. BUKOWSKI A, Hoyo C, Vielot NA, Graff M, et al
     Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
     BMC Cancer. 2023;23:1072.
     PubMed     Abstract available
     
     
     
126. LI X, Wei X, Liu X, Wang N, et al
     The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
     BMC Cancer. 2023;23:1052.
     PubMed     Abstract available
     
     
     October 2023
127. TSEGAYE K, Hagos A, Kindie H, Minyihun A, et al
     Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
     BMC Cancer. 2023;23:1034.
     PubMed     Abstract available
     
     
     
128. LV N, Zhao Y, Song Y, Ji M, et al
     Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
     BMC Cancer. 2023;23:1022.
     PubMed     Abstract available
     
     
     
129. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
     Correction: Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
     BMC Cancer. 2023;23:963.
     PubMed    
     
     
     
130. MISGUN T, Demissie DB
     Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia.
     BMC Cancer. 2023;23:961.
     PubMed     Abstract available
     
     
     
131. WANG J, Huang J, Ding H, Ma J, et al
     Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
     BMC Cancer. 2023;23:929.
     PubMed     Abstract available
     
     
     September 2023
132. SHAN M, Deng Y, Zou W, Fan S, et al
     Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
     BMC Cancer. 2023;23:905.
     PubMed     Abstract available
     
     
     
133. HE C, Pei C, Ma J
     Developing an evaluation indicators of health literacy for cervical cancer among Chinese women: a modified Delphi method study.
     BMC Cancer. 2023;23:863.
     PubMed     Abstract available
     
     
     
134. WANG F, Song S, Guo B, Li Y, et al
     Increased TCP11 gene expression can inhibit the proliferation, migration and promote apoptosis of cervical cancer cells.
     BMC Cancer. 2023;23:853.
     PubMed     Abstract available
     
     
     
135. ZHU M, Li X, Feng Y, Jia T, et al
     Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study.
     BMC Cancer. 2023;23:845.
     PubMed     Abstract available
     
     
     
136. CHETTY-SEBASTIAN D, Assounga AG
     Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
     BMC Cancer. 2023;23:830.
     PubMed     Abstract available
     
     
     
137. O'DOWD EL, Merriel SWD, Cheng VWT, Khan S, et al
     Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
     BMC Cancer. 2023;23:820.
     PubMed     Abstract available
     
     
     
138. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
     Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
     BMC Cancer. 2023;23:819.
     PubMed     Abstract available
     
     
     August 2023
139. SAMADI M, Mokhtari-Azad T, Nejati A, Norooz-Babaei Z, et al
     The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
     BMC Cancer. 2023;23:803.
     PubMed     Abstract available
     
     
     
140. DADIPOOR S, Alavi A, Kader Z, Mohseni S, et al
     Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.
     BMC Cancer. 2023;23:730.
     PubMed     Abstract available
     
     
     July 2023
141. ZHANG C, Gu L, Xiao J, Jin F, et al
     Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
     BMC Cancer. 2023;23:684.
     PubMed     Abstract available
     
     
     
142. MUSA J, Maiga M, Green SJ, Magaji FA, et al
     Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
     BMC Cancer. 2023;23:683.
     PubMed     Abstract available
     
     
     
143. MARTINEZ-GUTIERREZ J, Chima S, Boyd L, Sherwani A, et al
     Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
     BMC Cancer. 2023;23:653.
     PubMed     Abstract available
     
     
     
144. NAJJEMBA JI, Ndagire R, Mulamira P, Kibudde S, et al
     Treatment compliance among adult cervical cancer patients receiving care at Uganda cancer institute, Uganda: a retrospective data review.
     BMC Cancer. 2023;23:631.
     PubMed     Abstract available
     
     
     June 2023
145. PENG H, Zhang J, Xu N, Zhou Y, et al
     Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
     BMC Cancer. 2023;23:588.
     PubMed     Abstract available
     
     
     May 2023
146. WU J, Guo Q, Zhu J, Wu Y, et al
     Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
     BMC Cancer. 2023;23:485.
     PubMed     Abstract available
     
     
     
147. JIANG Y, Wang J, Jiang P, Wang X, et al
     Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
     BMC Cancer. 2023;23:481.
     PubMed     Abstract available
     
     
     
148. BELAY AS, Asmare WN, Kassie A
     Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model.
     BMC Cancer. 2023;23:472.
     PubMed     Abstract available
     
     
     
149. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
     Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
     BMC Cancer. 2023;23:466.
     PubMed     Abstract available
     
     
     
150. MATOVU JK, Wagner GJ, Juncker M, Namisango E, et al
     Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
     BMC Cancer. 2023;23:428.
     PubMed     Abstract available
     
     
     
151. YE Y, Li Z, Kang S, Yang Y, et al
     Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
     BMC Cancer. 2023;23:421.
     PubMed     Abstract available
     
     
     
152. BOOTH BB, Tranberg M, Gustafson LW, Christiansen AG, et al
     Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged >/= 69 referred to colposcopy due to an HPV-positive screening test.
     BMC Cancer. 2023;23:405.
     PubMed     Abstract available
     
     
     April 2023
153. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
     Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
     BMC Cancer. 2023;23:385.
     PubMed     Abstract available
     
     
     
154. GAN Q, Huang X, Zhao W, Liu H, et al
     AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
     BMC Cancer. 2023;23:364.
     PubMed     Abstract available
     
     
     
155. RAHIMI M, Akbari A, Asadi F, Emami H, et al
     Cervical cancer survival prediction by machine learning algorithms: a systematic review.
     BMC Cancer. 2023;23:341.
     PubMed     Abstract available
     
     
     March 2023
156. ZHANG H, Wang X, Li Y, Bai Y, et al
     The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.
     BMC Cancer. 2023;23:222.
     PubMed     Abstract available
     
     
     February 2023
157. QIN D, Bai A, Xue P, Seery S, et al
     Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology.
     BMC Cancer. 2023;23:187.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.